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Abstract
Objective: To update current estimates of non—device-associated urinary tract infection (ND-
UTI) rates and their frequency relative to catheter-associated UTIs (CA-UTIs) and to identify risk 
factors for ND-UTIs.
Design: Cohort study.
Setting: Academic teaching hospital.
Patients: All adult hospitalizations between 2013 and 2017 were included. UTIs (device and 
non-device associated) were captured through comprehensive, hospital-wide active surveillance 
using Centers for Disease Control and Prevention case definitions and methodology.
Results: From 2013 to 2017 there were 163,386 hospitalizations (97,485 unique patients) and 
1,273 UTIs (715 ND-UTIs and 558 CA-UTIs). The rate of ND-UTIs remained stable, decreasing 
slightly from 6.14 to 5.57 ND-UTIs per 10,000 hospitalization days during the study period (P 
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= .15). However, the proportion of UTIs that were non—device related increased from 52% to 
72% (P < .0001). Female sex (hazard ratio [HR], 1.94; 95% confidence interval [CI], 1.50–2.50) 
and increasing age were associated with increased ND-UTI risk. Additionally, the following 
conditions were associated with increased risk: peptic ulcer disease (HR, 2.25; 95% CI, 1.04–
4.86), immunosuppression (HR, 1.48; 95% CI, 1.15–1.91), trauma admissions (HR, 1.36; 95% CI, 
1.02–1.81), total parenteral nutrition (HR, 1.99; 95% CI, 1.35–2.94) and opioid use (HR, 1.62; 
95% CI, 1.10–2.32). Urinary retention (HR, 1.41; 95% CI, 0.96–2.07), suprapubic catheterization 
(HR, 2.28; 95% CI, 0.88–5.91), and nephrostomy tubes (HR, 2.02; 95% CI, 0.83–4.93) may also 
increase risk, but estimates were imprecise.
Conclusion: Greater than 70% of UTIs are now non—device associated. Current targeted 
surveillance practices should be reconsidered in light of this changing landscape. We identified 
several modifiable risk factors for ND-UTIs, and future research should explore the impact of 
prevention strategies that target these factors.
Healthcare-associated infections (HAIs) pose a major burden on the US healthcare system. 
HAIs are a substantial source of morbidity and mortality, and they are considered one of the 
most common sources of preventable harm in the inpatient setting.1–6 In 2015, 3.2% of 
patients, or roughly 1 in every 31 hospitalized adults, had at least 1 HAI on any given day in 
the United States, which corresponds to almost 700,000 infections a year.2 Urinary tract 
infection (UTI) is one of the most common types of HAI, accounting for almost 15% of all 
HAIs and one-third of HAIs outside of intensive care units.1–3 Although mortality and cost 
of UTIs may be lower than other HAIs (2% and $589, respectively), the estimated overall 
burden is substantial because they are so common (13,000 deaths and $340 million per 
year).3,7
Historically, the vast majority of healthcare-associated UTIs have been considered catheter 
associated (ie, CA-UTIs).3,8,9 However, there is increasing appreciation that non—device-
associated UTIs (ND-UTIs) account for a substantial fraction and sometimes the majority of 
hospital-onset UTIs. Rates of CA-UTIs have dramatically decreased over the past decade, 
but the rate of ND-UTIs has remained stagnant.2,10–12 Despite the increasing importance of 
ND-UTIs in the acute-care setting, research on the incidence, risk factors, and optimal 
prevention strategies for these infections is scarce. Thus, the purposes of this study were (1) 
to update current estimates of ND-UTI rates and their frequency relative to CA-UTI, (2) to 
assess temporal trends, and (3) to identify potential risk factors for ND-UTIs.
Methods
Data sources and study population
The electronic medical record (EMR) for adults (≥18 years old) admitted to the University 
of North Carolina (UNC) Hospitals between January 1, 2013, and December 31, 2017, were 
obtained from the Carolina Data Warehouse for Health (CDW-H), a central repository for 
clinical and administrative data from the UNC Healthcare System. Prisoners were excluded 
from this analysis. Patients were able to have multiple hospitalizations during the study 
period. HAIs were identified through the UNC Hospitals’ Infection Prevention database, 
which included both device-associated and non—device-associated HAIs captured through 
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comprehensive, hospital-wide active surveillance in accordance with the Centers for Disease 
Control and Prevention (CDC) case definitions and methodology.11,13 The CDC definition 
of UTI (device and non—device associated) require the patient has at least 1 sign or 
symptom (eg, fever, suprapubic tenderness, urinary frequency, and/or urinary urgency) and a 
urine culture with a bacterium of either ≥103 CFU/mL (2013–2014 definition) or ≥105 
CFU/mL (2015–2017 definition). All diagnoses were reviewed and validated by 2 
independent reviewers. The 2 databases were then deterministically linked using admission 
date, medical record numbers, and full name. This study was approved by the UNC 
Institutional Review Board.
Incidence of ND-UTIs
Quarterly incidence rates, per 10,000 hospitalization days, between 2013 and 2017 were 
calculated, and Poisson regression was used to estimate potential changes in ND-UTI rates 
over time. The proportion of UTIs that were non—device related each year were also 
calculated. Cochran-Armitage trend tests (2-sided) were used to test the null hypothesis that 
the proportion of ND-UTIs did not change between 2013 and 2017. To be consistent with 
CDC rate calculations, all patients (irrespective of length of stay) were included.
Risk factors for ND-UTIs
Potential risk factors of interest included patient sex, age, comorbidities, 
immunosuppression, BMI, trauma admission, being on an intensive care unit (ICU), 
Modified Early Warning Score (MEWS), Morse Fall Scale (MFS), urinary retention, 
inpatient medications (eg, anesthesia, antibiotics, anticholinergics, benzodiazepines, and 
opioids), total parenteral nutrition (TPN), urinary catheterization, suprapubic catheterization, 
nephrostomy tube, and having undergone a urologic procedure. Details on how each risk 
factor was measured are included in the Supplemental Appendix. For this analysis, only 
hospitalizations between 2015 and 2017 (ie, after Epic was implemented) were included. 
Additionally, patients with a length of stay (LOS) <2 days were excluded because they are 
not at-risk for HAIs according to CDC definitions.
ICU stay, urinary retention, inpatient medications, TPN, device use, and urologic procedures 
were treated as time-varying exposures, with the patient being considered as exposed for the 
remainder of the hospitalization. For example, once a patient received antibiotics on day 4, 
they were considered to have been exposed from day 4 until discharge and were classified as 
unexposed on days 1–3. Multivariable Cox proportional hazards regression was used to 
simultaneously estimate the association between each potential risk factor and the incidence 
of ND-UTIs. Correlation between repeat hospitalizations of the same patients were taken 
into account by utilizing robust sandwich covariance matrix estimates, and CA-UTI and 
inpatient mortality were treated as competing risks.14,15
Due to missing values of BMI (n = 15,146, 17%), MEWS (n=18,761, 21%), MFS (n=8,571, 
10%), and location/discharge disposition (n = 8,482, 10%), inverse probability of missing 
weights (IPMWs) were calculated.16 Weights were estimated using multivariable logistic 
regression, which modeled the probability of being a complete case. Details on estimating 
IPMW can also be found in the Supplemental Appendix online. Because 99% of 
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hospitalizations from January to March 2015 were missing MEWSs (28% of all the missing 
data), all hospitalizations in this period were excluded from multivariable analysis.
Our statistical analysis strategy is consistent with the American Statistical Association’s 
statements on P values.17,18 All statistical computations were performed using SAS version 
9.4 software (SAS Institute, Cary, NC).
Results
From 2013 to 2017 there were 163,386 hospitalizations (97,485 unique patients); there were 
1,273 UTIs (715 ND-UTI, 558 CA-UTI) during 1,234 unique hospitalizations at UNC 
Hospitals. Of the 1,273 UTIs, 1,268 (99.6%) were successfully linked to a hospitalization 
record. Also, 142,836 hospitalizations (87%) were >2 days (median 5 days; interquartile 
range [IQR], 3–8 days). Patient demographics and causes of admission are described in 
Table 1.
The median time to first UTI was 8 days for both ND-UTIs (IQR, 4–15) and CA-UTIs (IQR, 
4–18). Between 2013 and 2017, the rate of ND-UTIs decreased slightly but overall remained 
stable, with 6.14 ND-UTIs per 10,000 hospitalization days in 2013 and 5.57 ND-UTIs per 
10,000 hospitalization days in 2017 (P = .15). However, the proportion of UTIs that were 
non—device related increased from 52% to 72% during this period (P < .0001) (Fig. 1). 
From 2015 to 2017, 49 ND-UTIs (15%) occurred in an ICU, 229 (70%) occurred on a floor, 
46 (14%) occurred on a stepdown unit, and 67 could not be classified due to missing 
location data. In comparison, 137 CA-UTIs (55%) occurred in an ICU, 81 (32%) occurred 
on the floor, 33 (13%) occurred on a stepdown unit, and 18 could not be classified. The 30-
day and 60-day cumulative incidences of ND-UTI were 19.9 and 48.7 infections per 10,000 
patients, respectively (Fig. 2).
Overall, 88,487 hospitalizations between 2015 and 2017 with a LOS >2 days were included 
in the risk factor analysis. Median IPMW was 1.07 (IQR, 1.03–1.24; range, 1.00–21.38). 
Only 27 hospitalizations had a weight >10. After adjustment, female sex (hazard ratio [HR], 
1.94; 95% confidence interval [CI], 1.50–2.50) and increasing age were associated with 
increased incidence of ND-UTIs, with patients ≥70 years old, compared to those 18–25 
years old, having the highest risk (HR, 2.06; 95% CI, 1.33–3.21) (Table 2). Moreover, the 
effect of female sex appeared to be relatively consistent across age (P = .57). Patients 
diagnosed with peptic ulcer disease (HR, 2.25; 95% CI, 1.04–4.86), patients who were 
immunosuppressed (HR, 1.48; 95% CI, 1.15–1.91), and patients admitted for trauma (HR, 
1.36; 95% CI, 1.02–1.81) were also at increased risk for ND-UTIs. BMI and MEWS did not 
appear to have any impact.
During the hospitalization, being given TPN (HR, 1.99; 95% CI, 1.35–2.94) and opioids 
(HR, 1.62; 95% CI, 1.10–2.32) were associated with increased patient risk of ND-UTI 
(Table 2). In the crude analyses, urinary retention, suprapubic catheterization, and 
nephrostomy tubes were associated with increased risk of infection, but after adjustment for 
possible confounders, confidence intervals were wide and effects were no longer statistically 
significant for urinary retention (HR, 1.41; 95% CI, 0.96–2.07), suprapubic catheterization 
Strassle et al. Page 4













(HR, 2.28; 95% CI, 0.88–5.91) and nephrostomy tubes (HR, 2.02; 95% CI, 0.83–4.93). 
Local anesthesia (HR, 0.70; 95% CI, 0.53–0.92), antibiotics (HR, 0.32; 95% CI, 0.24–0.43), 
nonantipsychotic anticholinergics (HR, 0.68; 95% CI, 0.53–0.87), and benzodiazepines (HR, 
0.66; 95% CI, 0.51–0.87) were associated with reduced risk of infection.
Discussion
Between 2013 and 2017, the incidence of ND-UTIs remained consistent, and 72% of UTIs 
are now non—device associated. Females, older adults, peptic ulcer disease, paralysis, 
immunosuppression, opioid use, TPN, and trauma patients were all at greater risk of ND-
UTI. Urinary retention, suprapubic catheters, and nephrostomy tubes also appeared to 
increase patient risk. To the best of our knowledge, this is the first robust and in-depth 
analysis of ND-UTI risk factors and the most recent assessment of ND-UTI incidence.
Over the past decade, the rate of ND-UTIs has remained relatively consistent, but the 
relative burden of ND-UTIs has increased. For example, from 2006 to 2009, 28% of all UTIs 
at UNC Hospitals were ND-UTIs and the rate of ND-UTIs was 6.4 infections per 10,000 
non—device days,10 but by 2012 this rate rose to almost 50%.12 As of 2017, the rate of ND-
UTI was 5.57 ND-UTIs per 10,000 hospitalization days and 3 of every 4 UTIs were non—
device associated. This shift toward non-device infections is likely due to implementation of 
evidence-based guidelines to prevent CA-UTI; these guidelines target catheter placement, 
maintenance, and removal and thus have a limited impact on preventing ND-UTIs.19,20 Our 
results suggest that current targeted surveillance practices directed at catheterized patients 
alone are no longer sufficient to capture the majority of UTIs in an acute-care setting.
Patient demographics and comorbidities, specifically female sex, older age, peptic ulcer 
disease, paralysis, and immunosuppression, were associated with increased ND-UTI 
incidence. Female sex, older age, paraplegia, and immunosuppression have also been shown 
to increase the risk for CA-UTIs, indicating that certain subsets of patients may be at higher 
risk for all UTIs.21–23 However, a recent study of CA-UTIs found that after accounting for 
comorbidities and other severity measures, age was no longer a predictor of infection, which 
likely means that age is a proxy for illness severity or frailty, and not an independent risk 
factor itself.23 To the best of our knowledge, peptic ulcer disease has not been reported to be 
a risk factor for UTIs (or CA-UTIs), but treatments such as ranitidine may cause drug-
induced urinary retention, particularly in new users, females, and those ≥60 years old.24,25 
However, peptic ulcer disease was associated with ND-UTI incidence even after adjusting 
for urinary retention, indicating that other factors may also be at play.
Inpatient medication use was also associated with ND-UTI incidence. Patients receiving 
antibiotics, local anesthetics, anticholinergics, and benzodiazepines were at reduced risk for 
infection, and patients receiving TPN and opioids were at increased risk. Opioids have also 
been found to cause drug-induced urinary retention,24 although opioid use may also be a 
proxy for acute pain and limited mobility (especially after surgery), which may increase risk 
for UTIs, particularly in older adults.26 Several studies have also found that TPN was 
associated with increased fungal infections, including UTIs, in hospitalized patients 
(although fungal infections were not included in our UTI definition).27,28 Interestingly, we 
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found that antibiotic use was associated with reduced incidence of ND-UTIs, even though 
antibiotic prophylaxis has not been found to reduce risk of CA-UTIs.19 Although local 
anesthetics, anticholinergics, and benzodiazepines are also known to cause urinary retention, 
anesthetics and benzodiazepines were associated with reduced risk of ND-UTIs, even in 
unadjusted analyses. Patients receiving these medications may represent an overall healthier 
patient population.
Finally, both suprapubic catheters and nephrostomy tubes were associated with increased 
incidence of ND-UTIs, but estimates were imprecise. A recent Cochrane review (2015) 
found little or no difference in symptomatic UTI risk between short-term suprapubic versus 
indwelling catheters, but patients with suprapubic catheters were catheterized for longer 
durations, which could explain the higher cumulative infection risk in this population.29 
Currently, neither suprapubic catheters nor nephrostomy tubes are included in the CDC CA-
UTI definition, and the CDC has no recommendations for preventing UTIs in these 
populations, although they do call for further research on the topic.19
This study has several limitations. First, we were unable to assess causality, and the risk 
factors we identified may only be indicators for the true underlying mechanisms. Second, 
this was a retrospective, single-center study, and our results may not be generalizable to 
other hospitals, particularly if the patient population is different. We also did not account for 
duration, dose, or underlying indications for medication use. Future studies should assess 
whether longer exposures or higher doses of opioids and other medications are associated 
with higher risk for ND-UTI. Additionally, The International Classification of Disease, 
Ninth Revision, Clinical Modifications (ICD-9-CM) and ICD-10-CM codes were used to 
identify most comorbidities. Using these codes likely underestimates the prevalence of 
comorbidities, although we expect this misclassification to be nondifferential and, if 
anything, to bias results toward the null. Similarly, ND-UTIs and CA-UTIs were captured 
using CDC definitions, which require laboratory confirmation. Patients treated for suspected 
UTIs but not cultured may have been missed. These definitions also changed in 2015; 
although the changes reduce the rates of diagnosed UTIs, we expected that the change would 
affect both ND-UTIs and CA-UTIs, and the trends we observed in ND-UTIs were consistent 
with 2006–2012 trends.10,12 We also only included postdefinitional change data in our risk 
factor analysis. Likewise, urinary retention was captured using suggestive medications; thus, 
patients managed without medications may also have been missed. We were also unable to 
assess intermittent catheterization in our analysis, which may also have increased a patient’s 
risk for ND-UTIs and was not included in the CDC CA-UTI definition.19,29 Finally, 
although we had a large sample size, the incidence of ND-UTI and prevalence of some risk 
factors were low, resulting in low levels of precision of the estimators, as indicated by the 
widths of the observed confidence intervals.
In conclusion, between 2013 and 2017, the incidence rate of ND-UTIs remained relatively 
stable, although non-device infections now represent the majority of diagnosed UTIs in our 
acute-care hospital. Current targeted surveillance practices for catheter-associated UTIs 
should be reconsidered in light of this changing landscape. Female gender, older age, peptic 
ulcer disease, paralysis, immunosuppression, trauma admissions, TPN, and opioids were all 
identified as potential risk factors for ND-UTI. Urinary retention, suprapubic catheters, and 
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nephrostomy tubes may also increase patient risk. Future research should attempt to 
replicate these findings and to explore the impact of prevention strategies that target these 
risk factors.
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Proportion of urinary tract infections (UTIs) that are device and non—device associated, 
stratified by year.
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Stacked cumulative incidences of non—device associated urinary tract infections (ND-UTIs, 
gray) and catheter-associated urinary tract infections (CA-UTIs, white).
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Total hospitalizations, no. 62,853 100,533
Unique patients, no. 41,941 64,633
Female, no. (%) 35,360 (56) 55,985 (56)
Age, median (IQR) 52 (34–66) 53 (35–66)
Race, no. (%)
 White 37,766 (62) 60,089 (62)
 Black 16,625 (27) 26,378 (27)
 Asian 752 (1) 1,411 (1)
 Hawaiian/Pacific Islander 31 (<1) 79 (<1)
 Native American 533 (1) 908 (1)
 Other race 5,159 (8) 8,166 (8)
 Missing 1,987 3,502
Cause of admission, no. (%)
a
 Circulatory disease 8,166 (13) 13,440 (14)
 Injury or poisoning
b
8,429 (13) 12,934 (13)
 Childbirth/complications of pregnancy 7,938 (13) 12,408 (13)
 Digestive disease 5,982 (10) 10,367 (11)
 Neoplasms 6,094 (10) 9,882 (10)
 Psychological disorders 4,485 (7) 6,738 (7)
 Infectious/parasitic disease 3,651 (6) 5,789 (6)
 Respiratory disease 2,977 (5) 4,674 (5)
 Musculoskeletal disease 2,286 (4) 4,462 (5)
 Endocrine/metabolic disease 1,959 (3) 3,233 (3)
 Genitourinary disease 2,106 (3) 3,313 (3)
 Nervous system disease 1,679 (3) 2,756 (3)
 Skin disease 1,116 (2) 1,778 (2)
 Blood disease 994 (2) 1,575 (2)
 Other or poorly defined 4,862 (8) 4,972 (5)
LOS, days, median (IQR) 5 (3–8) 5 (3–8)
Note. IQR, interquartile range; LOS, length of stay.
a
Classified using primary diagnosis on each hospitalization; 2,341 hospitalizations (1%) were unable to be linked to their diagnosis codes
b
A subset of these codes were used to identify trauma admissions
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